Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01162018 · ClinicalTrials.gov registry record · NA
Acupuncture for Sleep Disruption in Cancer Survivors
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT01162018: Completed NA study, sponsored by Stanford University.
NCT01162018 is a NA study that has completed, run by Stanford University. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01162018, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
The proposed study will recruit 60 women with breast cancer who finished undergoing treatment who complain of persistent insomnia problems that began with onset of their cancer diagnosis. The eligible women would be randomized and stratified by sleep problems to two arms: (Acupuncture Arm vs. Sham Acupuncture) with a goal of having 48 patients complete the study (we anticipate about 20% attrition rate). The study interventions will begin after patients completed their treatment. The placebo control for acupuncture will be a validated sham acupuncture control Assessments will be made with daily diaries and with weekly questionnaires. PSG data will be collected on the subsample of the population. Data will be gathered via pencil-and-paper measures before, during, immediately following, one month following the completion of treatment and six months after the conclusion of treatment. In addition, actigraphy data (objective sleep continuity data) will be acquired prior to and following treatment
Interventions
- OTHER placebo
- PROCEDURE acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2011-02 |
| Est. Completion | 2012-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01162018
The ClinicalTrials.gov registry entry for NCT01162018 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01162018 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01162018 about?
NCT01162018 is a clinical study titled "Acupuncture for Sleep Disruption in Cancer Survivors". The proposed study will recruit 60 women with breast cancer who finished undergoing treatment who complain of persistent insomnia problems that began with onset of their cancer diagnosis. The eligible women would be randomized and stratified by sleep problems to two arms: (Acupuncture Arm vs. Sham A...
What is the current status of trial NCT01162018?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2011-02. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01162018?
The interventions under investigation include: placebo (OTHER), acupuncture (PROCEDURE).
Who is sponsoring clinical trial NCT01162018?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.